Sonoma Pharmaceuticals logo
Sonoma Pharmaceuticals SNOA
$ 2.74 -1.75%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Sonoma Pharmaceuticals Financial Statements 2011-2024 | SNOA

Annual Financial Statements Sonoma Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.64 M 3.94 M 3.08 K 7.98 M 7.5 M 7.32 M 17.2 M 29 M 16.3 M 7.44 M 20.6 M 26.2 M 28.2 M 51.2 M

Shares

9.09 M 3.39 M 2.65 K 2 M 1.48 M 924 K 503 K 474 K 365 K 215 K 153 K 111 K 86.9 K 83.7 K

Historical Prices

0.18 1.16 1.16 4.56 7.26 4.36 6.39 49 45.4 51.8 64.3 157 192 331

Net Income

-4.84 M -5.15 M -5.09 M -3.95 M -2.95 M -11.8 M -14.3 M 9.27 M -10.2 M -8.2 M 3.74 M -5.43 M -7.33 M -7.95 M

Revenue

12.7 M 13.3 M 12.6 M 18.6 M 18.9 M 19 M 16.7 M 12.8 M 15.1 M 13.9 M 13.7 M 15.5 M 12.7 M 9.75 M

Cost of Revenue

7.99 M 8.8 M 8.64 M 12.1 M 9.81 M 10.1 M 9.35 M 7.16 M 6.72 M 6.57 M 5.27 M 4.71 M 4.03 M 3.61 M

Gross Profit

4.74 M 4.48 M 3.99 M 6.56 M 8.33 M 8.88 M 7.31 M 5.67 M 7.21 M 7.29 M 8.4 M 10.7 M 8.71 M 6.14 M

Operating Income

-4.7 M -4.57 M -5.89 M -3.45 M -7.39 M -11.3 M -14.2 M -13 M -14.7 M -6.66 M -6.05 M -3.37 M -6.47 M -7.5 M

Interest Expense

- - -10 K 12 K 16 K 33 K 40 K 3 K 3 K 3 K 1.06 M 1.11 M 931 K 406 K

EBITDA

-4.52 M -4.44 M -5.7 M -3.22 M -6.36 M -10.8 M -13.7 M -12.7 M -9.91 M -6.41 M -5.77 M -3.11 M -6.14 M -7.11 M

Operating Expenses

9.45 M 9.05 M 9.88 M 10 M 15 M 20.1 M 21.5 M 18.6 M 17.4 M 13.9 M 14.4 M 14.1 M 15.2 M 13.6 M

General and Administrative Expenses

7.58 M 8.84 M 9.76 M 9.45 M 13.7 M 18.6 M 19.9 M 17.1 M 15.6 M 12.4 M 11.6 M 11.9 M 13.2 M 11.6 M

All numbers in USD currency

Quarterly Income Statement Sonoma Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

17 M 15.6 M 10.9 M 5.16 K 4.94 M 4.93 M 3.11 M 3.1 K 3.1 K 3.1 M 3.08 K 2.51 K 2.22 K 2.09 M 2.05 K 2.01 M 2.01 M 1.84 M 1.5 M 1.32 M 1.32 M 1.32 M 971 K 8.74 M 693 K 686 K 4.39 M 4.31 M 4.29 M 4.29 M 4.22 M 4.21 M 4.2 M 4.2 M 3.29 M 3.2 M 3.14 M 15 M 8.6 M 8.49 M 8.42 M 8.16 M 6.81 K 6.69 K 6.62 K 6.58 M 5.13 M 4.77 M 4.59 K 4.14 M 27 M 26.9 K 26.8 K 26.6 M

Net Income

-1.14 M - -866 K -1.48 M -1.42 M - -1.94 M -1.02 M -887 K - -944 K -2.14 M -1.1 M -1.1 M -650 K -650 K 120 K 240 K -1.08 M -1.08 M -1.2 M 715 K -2.3 M -2.3 M -2.82 M - -3.19 M -2.87 M -3.51 M - 16.2 M 11.7 M -4.52 M - -3.15 M -7.25 M -4.1 M - -5.91 M -6.7 M -788 K - -611 K -3.72 M -3.11 M - -1.91 M -2.99 M -1.07 M - -2.55 M -5.56 M -3.01 M -

Revenue

3.39 M - 3.14 M 2.73 M 3.43 M - 2.94 M 3.33 M 3.98 M - 2.9 M 10.3 M 7.43 M - 4.94 M 4.94 M 5.77 M 5.77 M 4.68 M 14.4 M 9.68 M - 5.28 M 5.28 M 4.94 M - 4.84 M 4.32 M 3.84 M - 3.36 M 8.8 M 5.44 M - 2.48 M 6.79 M 7.73 M - 3.22 M 9.87 M 6.66 M - 3.29 M 10.8 M 7.46 M - 3.54 M 12.1 M 8.58 M - 2.79 M 3.66 M 2.94 M -

Cost of Revenue

2.08 M - 1.68 M 1.74 M 2.22 M - 2.11 M 1.8 M 2.34 M - 1.7 M 6.43 M 4.73 M - 2.94 M 2.94 M 3.27 M 3.51 M 2.39 M 2.52 M 2.67 M 2.34 M 2.43 M 2.43 M 2.51 M - 2.48 M 2.48 M 2.07 M - 1.66 M 5.08 M 3.42 M - 2.03 M 5.12 M 3.77 M - 1.56 M 4.58 M 3.02 M - 1.18 M 3.74 M 2.56 M - 1.07 M 3.56 M 32 K - 938 K 2.81 M 20 K -

Gross Profit

1.31 M - 1.46 M 990 K 1.2 M - 831 K 1.54 M 1.65 M - 1.2 M 3.9 M 2.69 M - 2 M 2 M 2.5 M 2.26 M 2 M 2.16 M 2.29 M 2.37 M 2.85 M 2.85 M 2.43 M - 2.37 M 1.85 M 1.76 M - 1.71 M 3.72 M 2.02 M - 455 K 1.68 M 3.96 M - 1.66 M 5.29 M 3.64 M - 2.11 M 7.01 M 4.9 M - 2.47 M 8.56 M 6.08 M - 1.85 M 6.58 M 4.73 M -

Operating Income

-1.17 M - -844 K -1.21 M -1.24 M - -1.83 M -731 K -855 K - -958 K -2.83 M -1.87 M - -138 K -138 K 169 K -665 K -1.11 M -982 K -1.2 M -1.73 M -2.35 M -2.35 M -2.65 M - -3.2 M -2.86 M -3.38 M - -3.56 M -10.1 M -6.5 M - -4.19 M -11.1 M -4.17 M - -1.95 M -5.01 M -3.06 M - -1.55 M -3.94 M -2.4 M - -680 K -1.99 M -1.31 M - -2.35 M -5 M -2.65 M -

Interest Expense

- - - - - - 1 K 4 K 3 K - 3 K -1 K -5 K - 5 K 12 K 6 K 2 K 1 K 1 K 2 K 10 K 7 K 7 K 7 K - 11 K 10 K 10 K - - 2 K 2 K - - 1 K 1 K - - 4 K 4 K - 618 K 1.06 M 438 K - 275 K 843 K 568 K - 260 K 652 K 392 K -

EBITDA

-1.13 M - - - -1.2 M - -1.83 M -640 K -824 K - -958 K -2.69 M -1.77 M - -138 K 49 K 276 K -612 K -1.11 M -770 K -1.06 M -1.65 M -2.35 M -2 M -2.41 M - -3.2 M -2.86 M -3.27 M - -3.56 M -9.88 M -6.38 M - -4.19 M -10.9 M -4.05 M - -1.95 M -4.82 M -2.96 M - -1.55 M -3.73 M -2.26 M - -680 K -1.8 M -1.18 M - -2.35 M -4.76 M -2.48 M -

Operating Expenses

2.48 M - 2.3 M 2.2 M 2.44 M - 2.66 M 2.27 M 2.5 M - 2.16 M 6.72 M 4.56 M - 2.13 M 2.13 M 2.33 M 2.92 M 3.11 M 3.14 M 3.5 M 4.1 M 5.2 M 5.2 M 5.08 M - 5.57 M 4.7 M 5.14 M - 5.27 M 13.8 M 8.51 M - 4.64 M 12.8 M 8.13 M - 3.6 M 10.3 M 6.7 M - 3.66 M 11 M 7.3 M - 3.15 M 10.5 M 7.4 M - 4.21 M 11.6 M 7.38 M -

General and Administrative Expenses

2.01 M - 1.7 M 1.66 M 2.12 M - 2.66 M 2.07 M 2.3 M - 2.14 M 6.6 M 4.47 M - 2.1 M 2.1 M 2.42 M 2.44 M 2.86 M 2.89 M 3.23 M 3.76 M 4.75 M 4.75 M 4.69 M - 5.22 M 4.34 M 4.76 M - 4.78 M 12.6 M 7.77 M - 4.16 M 11.4 M 7.25 M - 3.24 M 9.14 M 5.9 M - 2.88 M 8.79 M 5.91 M - 2.64 M 8.99 M 6.35 M - 3.7 M 10.1 M 6.38 M -

All numbers in USD currency